Found: 31
Select item for more details and to access through your institution.
Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37806-0
- By:
- Publication type:
- Article
Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 8, p. 1, doi. 10.1007/s11912-018-0709-7
- By:
- Publication type:
- Article
Current treatment paradigms for triple-negative breast cancer.
- Published in:
- Minerva Medica, 2024, v. 15, n. 5, p. 589, doi. 10.23736/S0026-4806.24.09458-8
- By:
- Publication type:
- Article
Roles of Notch Signaling in the Tumor Microenvironment.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 6241, doi. 10.3390/ijms23116241
- By:
- Publication type:
- Article
A contemporary review of male breast cancer: current evidence and unanswered questions.
- Published in:
- Cancer & Metastasis Reviews, 2018, v. 37, n. 4, p. 599, doi. 10.1007/s10555-018-9761-x
- By:
- Publication type:
- Article
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 200, n. 2, p. 217, doi. 10.1007/s10549-023-06959-3
- By:
- Publication type:
- Article
Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 195, n. 2, p. 127, doi. 10.1007/s10549-022-06602-7
- By:
- Publication type:
- Article
Surveillance mammography after treatment for male breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 194, n. 3, p. 693, doi. 10.1007/s10549-022-06645-w
- By:
- Publication type:
- Article
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 557, doi. 10.1007/s10549-020-06030-5
- By:
- Publication type:
- Article
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 182, n. 3, p. 613, doi. 10.1007/s10549-020-05709-z
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 1, p. 387, doi. 10.1007/s00520-020-05473-2
- By:
- Publication type:
- Article
PDJ amplicon in triple negative breast cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-27887-8
- By:
- Publication type:
- Article
The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 4, p. 2111, doi. 10.1245/s10434-020-09480-9
- By:
- Publication type:
- Article
Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603).
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1093/jncics/pkz088
- By:
- Publication type:
- Article
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-020-0147-1
- By:
- Publication type:
- Article
Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 4, p. 337, doi. 10.1001/jama.2024.10483
- By:
- Publication type:
- Article
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, p. 1135, doi. 10.1001/jama.2024.3056
- By:
- Publication type:
- Article
Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 8, p. 5132, doi. 10.1245/s10434-024-15583-4
- By:
- Publication type:
- Article
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 1, p. 89, doi. 10.1007/s10549-017-4499-7
- By:
- Publication type:
- Article
Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 691, doi. 10.1007/s00280-014-2501-1
- By:
- Publication type:
- Article
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response.
- Published in:
- NAR Cancer, 2022, v. 4, n. 2, p. 1, doi. 10.1093/narcan/zcac018
- By:
- Publication type:
- Article
Hypereosinophilic Syndrome Presenting As an Unusual Triad of Eosinophilia, Severe Thrombocytopenia, and Diffuse Arterial Thromboses, With Good Response to Mepolizumab.
- Published in:
- Clinical Advances in Hematology & Oncology, 2013, v. 11, n. 5, p. 317
- By:
- Publication type:
- Article
Mediastinal Extravasation of Oxaliplatin.
- Published in:
- Clinical Advances in Hematology & Oncology, 2012, v. 10, n. 8, p. 1
- By:
- Publication type:
- Article
Extravasation of Oxaliplatin into the Mediastinum: A Case Report and Review of the Literature.
- Published in:
- Clinical Advances in Hematology & Oncology, 2012, v. 10, n. 8, p. 1
- By:
- Publication type:
- Article
Reply to On the proportion of male breast cancer among all breast cancers.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00629-3
- By:
- Publication type:
- Article
Reply to On the proportion of male breast cancer among all breast cancers.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 9, p. 2034, doi. 10.1002/cncr.32727
- By:
- Publication type:
- Article
Fit for Chemo: Nerves May Thank You.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01848-z
- By:
- Publication type:
- Article
Identification of a Notch transcriptomic signature for breast cancer.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-023-01757-7
- By:
- Publication type:
- Article